| Financial Year |
March 31 2023 |
| Monetary Funds |
31,608,646.34 |
| Held-for-trading Financial Assets |
16,006,726.57 |
| Notes Receivable |
11,374,487.58 |
| Accounts Receivable |
96,357,331.66 |
| Advances to Suppliers |
1,296,330.48 |
| Other Receivables |
3,992,405.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
47,301,657.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
575,000.00 |
| Other Current Assets |
24,904,113.98 |
| Total Current Assets |
233,416,700.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
14,527,612.13 |
| Long-term Equity Investment |
-- |
| Investment Properties |
301,591,870.00 |
| Fixed Assetes |
38,547,479.33 |
| Under-construction Projects |
42,974,881.63 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,462,074.91 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
175,176.77 |
| Deferred Income Tax Assets |
5,094,662.62 |
| Other Non-Current Assets |
61,715,025.42 |
| Sub-Total of Non-Current Assets |
468,168,740.98 |
| Total Assets |
701,585,441.51 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,041,203.89 |
| Accounts Payable |
33,832,174.14 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,603,678.33 |
| Taxes Payable |
749,048.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
107,741.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,134,282.85 |
| Other Current Liabilities |
261,933.67 |
| Sub-Total of Current Liabilities |
46,744,937.89 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,814,147.58 |
| Deferred Income Tax Liabilities |
542,573.30 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,356,720.88 |
| Total Liabilities |
51,101,658.77 |
| Paid-In Capital(Or Share Stock) |
328,107,975.00 |
| Capital Surplus |
95,726,355.56 |
| Surplus Reserve |
44,879,814.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
180,167,713.19 |
| Minority Stockholder's Interest |
-1,466,939.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
651,950,722.37 |
| Owner's Equity（Stockholder's Equity） |
650,483,782.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
701,585,441.51 |
